FLT1 and COVID-19: Severe COVID-19 patients had significantly higher levels of CRP, ICAM-1, SAA, VCAM-1, CXCL10, IL-10, IL-15, IL-16, IL-7, Flt-1 and VEGF-D than mild or moderate COVID-19 patients.